Theravance Bio: Q2 Earnings Snapshot
GEORGE TOWN, Cayman Islands (AP) — GEORGE TOWN, Cayman Islands (AP) — Theravance Biopharma Inc. (TBPH) on Monday reported a loss of $15.6 million in its second quarter.
On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of 28 cents. Losses, adjusted for stock option expense and non-recurring costs, were 13 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The biopharmaceutical company posted revenue of $13.7 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $15.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH
